Simeon, J., Thrush, J., Bailey, TA. (2020) Angiopoietin-Like Protein 4 is a Chromatin Bound Protein that Enhances Mammosphere Formation and Triple Negative Breast Cancer Metastases. Department of Biological Sciences and Cell and Molecular Biology Graduate Program at the University of Arkansas at Fayetteville
Luan, H., Mohapatra, B., Bielecki, T., Mushtaq, I., Mirza, S., (Bailey) Jennings, T.A., Clubb, R., An, W., Ahmed, D., Storck, M., Sheinin, Y., Meza, J., Raja, S., Rakha, E., Band, V., and Band, H. 2018. Loss of the nuclear pool of ubiquitin ligase CHIP/STUB1 in breast cancer unleashes the MZF1-cathepsin pro-oncogenic program. Cancer Research (epub).
Bailey, T.A., Luan, H., Tom, E., Bielecki, T., Mohapatra, B., Ahmad, G., George, M., Kelly, D. L., Naratarajan, A., Raja,S.M., Band, V., Band,H. 2014. A Kinase Inhibitor Screen Reveals PKC-dependent Endocytic Recycling of ErbB2 in Breast Cancer Cells. The Journal of Biological Chemistry: 289; 30443-30458.
Bailey, T.A., Luan, H., Clubb, R.J., Naramura, M., Band,V., Raja,S.M., Band,H. 2011. Mechanisms of Trastuzumab resistance in ErbB2-driven breast cancer and newer opportunities to overcome therapy resistance. Journal of Carcinogenesis; 10:28.
Ortega-Cava, C.F., Raja,S.M., Laiq, Z., Bailey, T.A., Luan, H., Mohapatra,B., Williams, S.H., Ericsson, A.C., Goswami,R., Dimri, M., Duan, L., Band,V., Naramura, M., Band,H. 2011. Continuous requirement of ErbB2 kinase activity for loss of cell polarity and lumen formation in a novel ErbB2/Neu-driven murine cell line model of metastatic breast cancer. Journal of Carcinogenesis; 10:29.
Raja, S.M., Clubb, R.J., Ortega-Cava, C., Williams, S., Bailey, T.A., Duan, L., Zhao, X., Reddi, A. L., Nyong, A.M., Natarajan, A., Band, V., and Band, H. 2011. Anticancer activity of celastrol in combination with ErbB2-targeted therapeutics for treatment of ErbB2-overexpressing breast cancers. Cancer Biology and Therapy; 11:263-276.